338 related articles for article (PubMed ID: 34203247)
21. Atp6v0d2 is an essential component of the osteoclast-specific proton pump that mediates extracellular acidification in bone resorption.
Wu H; Xu G; Li YP
J Bone Miner Res; 2009 May; 24(5):871-85. PubMed ID: 19113919
[TBL] [Abstract][Full Text] [Related]
22. Specialized Roles for Actin in Osteoclasts: Unanswered Questions and Therapeutic Opportunities.
Han G; Zuo J; Holliday LS
Biomolecules; 2019 Jan; 9(1):. PubMed ID: 30634501
[TBL] [Abstract][Full Text] [Related]
23. Regulation and function of V-ATPases in physiology and disease.
Collins MP; Forgac M
Biochim Biophys Acta Biomembr; 2020 Dec; 1862(12):183341. PubMed ID: 32422136
[TBL] [Abstract][Full Text] [Related]
24. Diphyllin, a novel and naturally potent V-ATPase inhibitor, abrogates acidification of the osteoclastic resorption lacunae and bone resorption.
Sørensen MG; Henriksen K; Neutzsky-Wulff AV; Dziegiel MH; Karsdal MA
J Bone Miner Res; 2007 Oct; 22(10):1640-8. PubMed ID: 17576165
[TBL] [Abstract][Full Text] [Related]
25. Murine ameloblasts are immunonegative for Tcirg1, the v-H-ATPase subunit essential for the osteoclast plasma proton pump.
Bronckers AL; Lyaruu DM; Bervoets TJ; Medina JF; DenBesten P; Richter J; Everts V
Bone; 2012 Apr; 50(4):901-8. PubMed ID: 22245629
[TBL] [Abstract][Full Text] [Related]
26. Bovine parathyroid hormone enhances osteoclast bone resorption by modulating V-ATPase through PTH1R.
Liu S; Zhu W; Li S; Ma J; Zhang H; Li Z; Zhang L; Zhang B; Li Z; Liang X; Shi W
Int J Mol Med; 2016 Feb; 37(2):284-92. PubMed ID: 26647715
[TBL] [Abstract][Full Text] [Related]
27. Functional complementation of V-ATPase a subunit isoforms in osteoclasts.
Matsumoto N; Sekiya M; Fujimoto Y; Haga S; Sun-Wada GH; Wada Y; Nakanishi-Matsui M
J Biochem; 2021 Apr; 169(4):459-466. PubMed ID: 33135054
[TBL] [Abstract][Full Text] [Related]
28. Osteoclast rich osteopetrosis due to defects in the TCIRG1 gene.
Capo V; Abinun M; Villa A
Bone; 2022 Dec; 165():116519. PubMed ID: 35981697
[TBL] [Abstract][Full Text] [Related]
29. From lysosomes to the plasma membrane: localization of vacuolar-type H+ -ATPase with the a3 isoform during osteoclast differentiation.
Toyomura T; Murata Y; Yamamoto A; Oka T; Sun-Wada GH; Wada Y; Futai M
J Biol Chem; 2003 Jun; 278(24):22023-30. PubMed ID: 12672822
[TBL] [Abstract][Full Text] [Related]
30. Vacuolar ATPase as a drug discovery target.
Niikura K
Drug News Perspect; 2006 Apr; 19(3):139-44. PubMed ID: 16804565
[TBL] [Abstract][Full Text] [Related]
31. Optic nerve compression and retinal degeneration in Tcirg1 mutant mice lacking the vacuolar-type H-ATPase a3 subunit.
Kawamura N; Tabata H; Sun-Wada GH; Wada Y
PLoS One; 2010 Aug; 5(8):e12086. PubMed ID: 20711468
[TBL] [Abstract][Full Text] [Related]
32. The vacuolar ATPase in bone cells: a potential therapeutic target in osteoporosis.
Yuan FL; Li X; Lu WG; Li CW; Li JP; Wang Y
Mol Biol Rep; 2010 Oct; 37(7):3561-6. PubMed ID: 20182803
[TBL] [Abstract][Full Text] [Related]
33. Vacuolar-type ATPase: A proton pump to lysosomal trafficking.
Futai M; Sun-Wada GH; Wada Y; Matsumoto N; Nakanishi-Matsui M
Proc Jpn Acad Ser B Phys Biol Sci; 2019; 95(6):261-277. PubMed ID: 31189779
[TBL] [Abstract][Full Text] [Related]
34. Lentiviral gene transfer of TCIRG1 into peripheral blood CD34(+) cells restores osteoclast function in infantile malignant osteopetrosis.
Moscatelli I; Thudium CS; Flores C; Schulz A; Askmyr M; Gudmann NS; Andersen NM; Porras O; Karsdal MA; Villa A; Fasth A; Henriksen K; Richter J
Bone; 2013 Nov; 57(1):1-9. PubMed ID: 23907031
[TBL] [Abstract][Full Text] [Related]
35. V-ATPases Containing a3 Subunit Play a Direct Role in Enamel Development in Mice.
Johnson L; Ganss B; Wang A; Zirngibl RA; Johnson DE; Owen C; Bradley G; Voronov I
J Cell Biochem; 2017 Oct; 118(10):3328-3340. PubMed ID: 28295540
[TBL] [Abstract][Full Text] [Related]
36. Vacuolar H+-ATPase d2 subunit: molecular characterization, developmental regulation, and localization to specialized proton pumps in kidney and bone.
Smith AN; Jouret F; Bord S; Borthwick KJ; Al-Lamki RS; Wagner CA; Ireland DC; Cormier-Daire V; Frattini A; Villa A; Kornak U; Devuyst O; Karet FE
J Am Soc Nephrol; 2005 May; 16(5):1245-56. PubMed ID: 15800125
[TBL] [Abstract][Full Text] [Related]
37. Atp6v1c1 is an essential component of the osteoclast proton pump and in F-actin ring formation in osteoclasts.
Feng S; Deng L; Chen W; Shao J; Xu G; Li YP
Biochem J; 2009 Jan; 417(1):195-203. PubMed ID: 18657050
[TBL] [Abstract][Full Text] [Related]
38. Versatile roles of V-ATPases accessory subunit Ac45 in osteoclast formation and function.
Qin A; Cheng TS; Lin Z; Pavlos NJ; Jiang Q; Xu J; Dai KR; Zheng MH
PLoS One; 2011; 6(11):e27155. PubMed ID: 22087256
[TBL] [Abstract][Full Text] [Related]
39. Regulation and isoform function of the V-ATPases.
Toei M; Saum R; Forgac M
Biochemistry; 2010 Jun; 49(23):4715-23. PubMed ID: 20450191
[TBL] [Abstract][Full Text] [Related]
40. The R740S mutation in the V-ATPase a3 subunit increases lysosomal pH, impairs NFATc1 translocation, and decreases in vitro osteoclastogenesis.
Voronov I; Ochotny N; Jaumouillé V; Owen C; Manolson MF; Aubin JE
J Bone Miner Res; 2013 Jan; 28(1):108-18. PubMed ID: 22865292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
